drugset / Trial / NCT00498550
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Phase 4
Completed
31 enrolled
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA) · collabUniversity of Missouri, Kansas City · collabUniversity of South Carolina · collabVA Medical Center-West Los Angeles · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Many individuals with schizophrenia also suffer from marijuana addiction. Clozapine, an atypical antipsychotic medication, may prove useful at preventing drug relapse in schizophrenic individuals who are seeking treatment for marijuana addiction. The purpose of this study is to compare the effectiveness of clozapine, vs. treatment-as-usual with other oral antipsychotics at reducing marijuana use in schizophrenic individuals.
Timeline
- Start
- 2000-10
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clozapine | Other / unclassified | 550 mg | — |